Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 2 years ago

Possible Interaction: Desipramine and Gamma-Aminobutyric Acid

Research Papers that Mention the Interaction

The inhibitory effect of GABA was facilitated by concurrent application of desipramine , carbamazepine or diazepam at a concentration of 5 x 10(-5)-2 x 10(-4) M. The rank of order of facilitation is: desipramine > carbamazepine > diazepam.
Japanese journal of pharmacology  •  2001  |  View Paper
Both compounds substantially attenuated the enhancement of the inhibitory responses to GABA produced by NE, with MDL 26,479 having a more marked effect than DMI.
Neuropharmacology  •  1990  |  View Paper
A decreased efficacy of NE action after DMI pretreatment was manifested in both a higher mean iontophoretic current dose of the catecholamine required to induce threshold depressions of Purkinje cell spontaneous activity and a markedly diminished ability of NE to enhance inhibitory responses to gamma-aminobutyric acid.
The Journal of pharmacology and experimental therapeutics  •  1983  |  View Paper
Added to the perfusion medium at a concentration of 10 μmol L‐1, DMI caused a 5‐ to 10‐fold increase in the release of GABA.
Journal of neurochemistry  •  1983  |  View Paper
Pargyline and desipramine increased the brain concentration of GABA but were without effect on GABA production.
General pharmacology  •  1976  |  View Paper
Abstract In mice, intraperitoneal administration of desipramine (12·5–100 mg/kg) or pargyline (25–200 mg/kg) reliably elevated the brain concentration of gamma-aminobutyric acid in a dose-dependent manner.
Biochemical pharmacology  •  1975  |  View Paper